Use the Back button in your browser to see the other results of your search or to select another record.
| Dose-response relationship of physical exercise interventions for balance performance in children and adolescents with intellectual disabilities: a systematic review and meta-analysis |
| Gao Z, Li Y, Wang Y, Quan W, Meng H, Kang J |
| Frontiers in Public Health 2025 Sep 25;13(1686892):Epub |
| systematic review |
|
OBJECTIVE: To systematically evaluate the impact of exercise interventions on balance performance in children and adolescents with intellectual disabilities and examine the dose-response relationship of key intervention parameters. METHODS: A comprehensive search of PubMed, Web of Science, Embase, Scopus, and the Cochrane Library identified eligible randomized controlled trials (RCTs). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and non-linear meta-regression were performed to explore potential effect modifiers and dose-response patterns. RESULTS: A total of 23 eligible studies comprising 31 datasets and 1,179 participants were included. Pooled analysis showed significant improvement in balance performance (SMD 0.69, 95% CI 0.48 to 0.89, p < 0.001). Dose-response modeling indicated maximal benefit at approximately 717 MET. min/week (Hedges' g 0.76). Subgroup analyses revealed greater effects with a frequency of >= 3 sessions/week (SMD 0.76, 95% CI 0.48 to 1.03, p < 0.001), session duration > 60 min (SMD 0.82, 95% CI 0.35 to 1.29, p = 0.001), and intervention period < 8 weeks (SMD 0.78, 95% CI 0.46 to 1.10, p < 0.001). CONCLUSION: Moderate-dose exercise (717 MET. min/week) can significantly improve the balance performance in children and adolescents with intellectual disabilities, with specific frequency, duration, and intervention period combinations yielding superior outcomes. These findings provide an evidence-based basis for precision health strategies. However, moderate heterogeneity highlights the need for confirmation through larger, multicenter, and long-term trials.
|